Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Change in Working Capital history
Currency unavailable · from the cash flow
No Change in Working Capital data reported for this period type.
Change in Working Capital vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | $16.17M USD | — | — | — |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | $10.9M USD | -374.2% | +68.3% | — |
| LTM Mar 2026 | $9.02M USD | +99.7% | — | — | |
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | $3.17M USD | -22.0% | +33.0% | 15.8% |
| LTM Mar 2026 | $2.34M USD | +115.1% | +11.0% | 1.1% | |
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | $677K USD | -103.7% | -60.2% | — |
| LTM Mar 2026 | $495.64K USD | +217.7% | — | — | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +38.8% | +22.0% | 8.5% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.